Genetics of human neural tube defects

Human Molecular Genetics

Volumn 18, Issue R2, 2009, Pages

  Greene, Nicholas D E ^a   Stanier, Philip ^a   Copp, Andrew J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ANIMAL; BIOLOGICAL MODEL; GENETICS; HUMAN; METABOLISM; MOUSE; NEURAL TUBE DEFECT; REVIEW;

ANIMALS; FOLIC ACID; HUMANS; MICE; MODELS, BIOLOGICAL; NEURAL TUBE DEFECTS;

EID: 73949160160     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddp347     Document Type: Article

References (163)

1. Detrait, E.R., George, T.M., Etchevers, H.C., Gilbert, J.R., Vekemans, M. and Speer, M.C. (2005) Human neural tube defects: developmental biology, epidemiology, and genetics. Neurotoxicol. Teratol., 27, 515-524.
2. Harris, M.J. and Juriloff, D.M. (2007) Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects. Birth Defects Res. A Clin Mol. Teratol., 79, 187-210.
3. Kennedy, D., Chitayat, D., Winsor, E.J.T., Silver, M. and Toi, A. (1998) Prenatally diagnosed neural tube defects: ultrasound, chromosome, and autopsy or postnatal findings in 212 cases. Am. J. Med. Genet., 77, 317-321.
4. Chen, C.P. (2007) Chromosomal abnormalities associated with neural tube defects (I): full aneuploidy. Taiwan J Obstet. Gynecol., 46, 325-335.
5. Chen, C.P. (2007) Chromosomal abnormalities associated with neural tube defects (II): partial aneuploidy. Taiwan J Obstet. Gynecol., 46, 336-351.
6. Rampersaud, E., Bassuk, A.G., Enterline, D.S., George, T.M., Siegel, D.G., Melvin, E.C., Aben, J., Allen, J., Aylsworth, A., Brei, T. et al. (2005) Whole genomewide linkage screen for neural tube defects reveals regions of interest on chromosomes 7 and 10. J. Med. Genet., 42, 940-946.
7. Stamm, D.S., Rampersaud, E., Slifer, S.H., Mehltretter, L., Siegel, D.G., Xie, J., Hu-Lince, D., Craig, D.W., Stephan, D.A., George, T.M. et al. (2006) High-density single nucleotide polymorphism screen in a large multiplex neural tube defect family refines linkage to loci at 7p21.1-pter and 2q33.1-q35. Birth Defects Res. A Clin. Mol. Teratol., 76, 499-505.
8. Stamm, D.S., Siegel, D.G., Mehltretter, L., Connelly, J.J., Trott, A., Ellis, N., Zismann, V., Stephan, D.A., George, T.M., Vekemans, M. et al. (2008) Refinement of 2q and 7p loci in a large multiplex NTD family. Birth Defects Res. A Clin. Mol. Teratol., 82, 441-452.
9. Goetzinger, K.R., Stamilio, D.M., Dicke, J.M., Macones, G.A. and Odibo, A.O. (2008) Evaluating the incidence and likelihood ratios for chromosomal abnormalities in fetuses with common central nervous system malformations. Am. J. Obstet. Gynecol., 199, 285-286.
10. Gustavsson, P., Schoumans, J., Staaf, J., Borg, A., Nordenskjold, M. and Anneren, G. (2007) Duplication 16q12.1-q22.1 characterized by array CGH in a girl with spina bifida. Eur. J. Med. Genet., 50, 237-241.
11. Boyles, A.L., Hammock, P. and Speer, M.C. (2005) Candidate gene analysis in human neural tube defects. Am. J. Med. Genet. C Semin. Med. Genet., 135, 9-23.
12. Frey, L. and Hauser, W.A. (2003) Epidemiology of neural tube defects. Epilepsia, 44, 4-13.
13. Mitchell, L.E. (2005) Epidemiology of neural tube defects. Am. J. Med. Genet., 135C, 88-94.
14. Carmichael, S.L., Witte, J.S. and Shaw, G.M. (2009) Nutrient pathways and neural tube defects: a semi-Bayesian hierarchical analysis. Epidemiology, 20, 67-73.
15. Blom, H.J., Shaw, G.M., Den Heijer, M. and Finnell, R.H. (2006) Neural tube defects and folate: case far from closed. Nat. Rev. Neurosci., 7, 724-731.
16. Beaudin, A.E. and Stover, P.J. (2007) Folate-mediated one-carbon metabolism and neural tube defects: balancing genome synthesis and gene expression. Birth Defects Res. C Embryo. Today, 81, 183-203.
17. Smithells, R.W., Sheppard, S., Schorah, C.J., Seller, M.J., Nevin, N.C., Harris, R., Read, A.P. and Fielding, D.W. (1980) Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet, 1, 339-340.
18. Wald, N., Sneddon, J., Densem, J., Frost, C. and Stone, R. MRC Vitamin Study Res Group (1991) Prevention of neural tube defects: results of the medical research council vitamin study. Lancet, 338, 131-137.
19. Kirke, P.N., Molloy, A.M., Daly, L.E., Burke, H., Weir, D.G. and Scott, J.M. (1993) Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q. J. Med., 86, 703-708.
20. Steegers-Theunissen, R.P.M., Boers, G.H.J., Trijbels, F.J.M., Finkelstein, J.D., Blom, H.J., Thomas, C.M.G., Borm, G.F., Wouters, M.G.A.J. and Eskes, T.K.A.B. (1994) Maternal hyperhomocysteinemia: a risk factor for neural tube defects. Metabolism, 43, 1475-1480.
21. Mills, J.L., McPartlin, J.M., Kirke, P.N., Lee, Y.J., Conley, M.R., Weir, D.G. and Scott, J.M. (1995) Homocysteine metabolism in pregnancies complicated by neural- tube defects. Lancet, 345, 149-151.
22. Scott, J.M. (1999) Folate and vitamin B12. Proc. Nutr. Soc., 58, 441-448.
23. Greene, N.D., Massa, V. and Copp, A.J. (2009) Understanding the causes and prevention of neural tube defects: insights from the splotch mouse model. Birth Defects Res. A Clin. Mol. Teratol., 85, 322-330.
24. Burren, K.A., Savery, D., Massa, V., Kok, R.M., Scott, J.M., Blom, H.J., Copp, A.J. and Greene, N.D.E. (2008) Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function. Hum. Mol. Genet., 17, 3675-3685.
25. Copp, A.J., Greene, N.D.E. and Murdoch, J.N. (2003) The genetic basis of mammalian neurulation. Nat. Rev. Genet., 4, 784-793.
26. Dunlevy, L.P.E., Burren, K.A., Chitty, L.S., Copp, A.J. and Greene, N.D.E. (2006) Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryos. FEBS Lett., 580, 2803-2807.
27. Dunlevy, L.P.E., Burren, K.A., Mills, K., Chitty, L.S., Copp, A.J. and Greene, N.D.E. (2006) Integrity of the methylation cycle is essential for mammalian neural tube closure. Birth Defects Res. (Part A), 76, 544-552.
28. Okano, M., Bell, D.W., Haber, D.A. and Li, E. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell, 99, 247-257.
29. VanAerts, L.A.G.J.M., Blom, H.J., Deabreu, R.A., Trijbels, F.J.M., Eskes, T.K.A.B., Peereboom-Stegeman, J.H.J.C. and Noordhoek, J. (1994) Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology, 50, 348-360.
30. Greene, N.D.E., Dunlevy, L.E. and Copp, A.J. (2003) Homocysteine is embryotoxic but does not cause neural tube defects in mouse embryos. Anat. Embryol., 206, 185-191.
31. Bennett, G.D., Vanwaes, J., Moser, K., Chaudoin, T., Starr, L. and Rosenquist, T.H. (2006) Failure of homocysteine to induce neural tube defects in a mouse model. Birth Defects Res. B Dev. Reprod. Toxicol., 77, 89-94.
32. Molloy, A.M., Brody, L.C., Mills, J.L., Scott, J.M. and Kirke, P.N. (2009) The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol., 85, 285-294.
33. Beaudin, A.E. and Stover, P.J. (2009) Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. Birth Defects Res. A Clin Mol. Teratol, 85, 274-284.
34. Dunlevy, L.P.E., Chitty, L.S., Doudney, K., Burren, K.A., Stojilkovic-Mikic, T., Stanier, P., Scott, R., Copp, A.J. and Greene, N.D.E. (2007) Abnormal folate metabolism in foetuses affected by neural tube defects. Brain, 130, 1043-1049.
35. Frosst, P., Blom, H.J., Milos, R., Goyette, P., Sheppard, C.A., Matthews, R.G., Boers, G.J.H., Den Heijer, M., Kluijtmans, L.A.J., Van den Heuvel, L.P. et al. (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Genet., 10, 111-113.
36. Van der Put, N.M.J., Steegers-Theunissen, R.P.M., Frosst, P., Trijbels, F.J.M., Eskes, T.K.A.B., Van den Heuvel, L.P., Mariman, E.C.M., Den Heyer, M., Rozen, R. and Blom, H.J. (1995) Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida. Lancet, 346, 1070-1071.
37. Shields, D.C., Kirke, P.N., Mills, J.L., Ramsbottom, D., Molloy, A.M., Burke, H., Weir, D.G., Scott, J.M. and Whitehead, A.S. (1999) The 'thermolabile' variant of methylenetetrahydrofolate reductase and neural tube defects: an evaluation of genetic risk and the relative importance of the genotypes of the embryo and the mother. Am. J. Hum. Genet., 64, 1045-1055.
38. Stegmann, K., Ziegler, A., Ngo, E.T.K.M., Kohlschmidt, N., Schröter, B., Ermert, A. and Koch, M.C. (1999) Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the german population and association studies in probands with neural tube defects(NTD). Am. J. Med. Genet., 87, 23-29.
39. Boyles, A.L., Billups, A.V., Deak, K.L., Siegel, D.G., Mehltretter, L., Slifer, S.H., Bassuk, A.G., Kessler, J.A., Reed, M.C., Nijhout, H.F. et al. (2006) Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ. Health Perspect., 114, 1547-1552.
40. De Marco, P., Calevo, M.G., Moroni, A., Arata, L., Merello, E., Finnell, R.H., Zhu, H., Andreussi, L., Cama, A. and Capra, V. (2002) Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J. Hum. Genet., 47, 319-324.
41. Doudney, K., Grinham, J., Whittaker, J., Lynch, S.A., Thompson, D., Moore, G.E., Copp, A.J., Greene, N.D.E. and Stanier, P. (2009) Evaluation of folate metabolism gene polymorphisms as risk factors for open and closed neural tube defects. Am. J. Med. Genet., 149A, 1585-1589.
42. Amorim, M.R., Lima, M.A., Castilla, E.E. and Orioli, I.M. (2007) Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C.T: a meta-analysis. Am. J. Med. Genet. A, 143A, 1726-1732.
43. Chen, Z.T., Karaplis, A.C., Ackerman, S.L., Pogribny, I.P., Melnyk, S., Lussier-Cacan, S., Chen, M.F., Pai, A., John, S.W.M., Smith, R.S. et al. (2001) Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. Hum. Mol. Genet., 10, 433-443.
44. Li, D., Pickell, L., Liu, Y., Wu, Q., Cohn, J.S. and Rozen, R. (2005) Maternal methylenetetrahydrofolate reductase deficiency and low dietary folate lead to adverse reproductive outcomes and congenital heart defects in mice. Am. J. Clin. Nutr., 82, 188-195.
45. Li, D., Pickell, L., Liu, Y. and Rozen, R. (2006) Impact of methylenetetrahydrofolate reductase deficiency and low dietary folate on the development of neural tube defects in splotch mice. Birth Defects Res. A Clin. Mol. Teratol., 76, 55-59.
46. Swanson, D.A., Liu, M.L., Baker, P.J., Garrett, L., Stitzel, M., Wu, J.M., Harris, M., Banerjee, R., Shane, B. and Brody, L.C. (2001) Targeted disruption of the methionine synthase gene in mice. Mol. Cell. Biol., 21, 1058-1065.
47. Elmore, C.L., Wu, X., Leclerc, D., Watson, E.D., Bottiglieri, T., Krupenko, N.I., Krupenko, S.A., Cross, J.C., Rozen, R., Gravel, R.A. et al. (2007) Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol. Genet. Metab., 91, 85-97.
48. Watanabe, M., Osada, J., Aratani, Y., Kluckman, K., Reddick, R., Malinow, M.R. and Maeda, N. (1995) Mice deficient in cystathionine b-synthase: Animal models for mild and severe homocyst(e)inemia. Proc. Natl. Acad. Sci. U.S.A., 92, 1585-1589.
49. Brody, L.C., Conley, M., Cox, C., Kirke, P.N., McKeever, M.P., Mills, J.L., Molloy, A.M., O'Leary, V.B., Parle-McDermott, A., Scott, J.M. et al. (2002) A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am. J. Hum. Genet., 71, 1207-1215.
50. Parle-McDermott, A., Kirke, P.N., Mills, J.L., Molloy, A.M., Cox, C., O'Leary, V.B., Pangilinan, F., Conley, M., Cleary, L., Brody, L.C. et al. (2006) Confirmation of the R653Q polymorphism of the trifunctional C1-synthase enzyme as a maternal risk for neural tube defects in the Irish population. Eur. J. Hum. Genet., 14, 768-772.
51. De Marco, P., Merello, E., Calevo, M.G., Mascelli, S., Raso, A., Cama, A. and Capra, V. (2006) Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G.A polymorphism for neural tube defect risk. J. Hum. Genet., 51, 98-103.
52. Van der Linden, I., Heil, S.G., Kouwenberg, I.C., den, H.M. and Blom, H.J. (2007) The methylenetetrahydrofolate dehydrogenase (MTHFD1) 1958G.A variant is not associated with spina bifida risk in the Dutch population. Clin. Genet., 72, 599-600.
53. Christensen, K.E., Rohlicek, C.V., Andelfinger, G.U., Michaud, J., Bigras, J.L., Richter, A., Mackenzie, R.E. and Rozen, R. (2009) The MTHFD1 p.Arg653Gln variant alters enzyme function and increases risk for congenital heart defects. Hum. Mutat., 30, 212-220.
54. Carroll, N., Pangilinan, F., Molloy, A.M., Troendle, J., Mills, J.L., Kirke, P.N., Brody, L.C., Scott, J.M. and Parle-McDermott, A. (2009) Analysis of the MTHFD1 promoter and risk of neural tube defects. Hum. Genet., 125, 247-256.
55. Jakubowski, H., Perla-Kajan, J., Finnell, R.H., Cabrera, R.M., Wang, H., Gupta, S., Kruger, W.D., Kraus, J.P. and Shih, D.M. (2009) Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice. FASEB J., 23, 1721-1727.
56. Franke, B., Vermeulen, S.H., Steegers-Theunissen, R.P., Coenen, M.J., Schijvenaars, M.M., Scheffer, H., den, H.M. and Blom, H.J. (2009) An association study of 45 folate-related genes in spina bifida: Involvement of cubilin (CUBN) and tRNA aspartic acid methyltransferase 1 (TRDMT1). Birth Defects Res. A Clin. Mol. Teratol., 85, 216-226.
57. Birn, H., Zhai, X., Holm, J., Hansen, S.I., Jacobsen, C., Christensen, E.I. and Moestrup, S.K. (2005) Megalin binds and mediates cellular internalization of folate binding protein. FEBS J., 272, 4423-4430.
58. Christensen, E.I. and Birn, H. (2002) Megalin and cubilin: multifunctional endocytic receptors. Nat. Rev. Mol. Cell Biol., 3, 256-266.
59. Gelineau-van Waes, J., Maddox, J.R., Smith, L.M., van, W.M., Wilberding, J., Eudy, J.D., Bauer, L.K. and Finnell, R.H. (2008) Microarray analysis of E9.5 reduced folate carrier (RFC1; Slc19a1) knockout embryos reveals altered expression of genes in the cubilin- megalin multiligand endocytic receptor complex. BMC Genomics, 9, 156.
60. Wu, J.I., Rajendra, R., Barsi, J.C., Durfee, L., Benito, E., Gao, G., Kuruvilla, M., Hrdlickova, R., Liss, A.S. and Artzt, K. (2007) Targeted disruption of Mib2 causes exencephaly with a variable penetrance. Genesis, 45, 722-727.
61. Narimatsu, M., Bose, R., Pye, M., Zhang, L., Miller, B., Ching, P., Sakuma, R., Luga, V., Roncari, L., Attisano, L. et al. (2009) Regulation of planar cell polarity by Smurf ubiquitin ligases. Cell, 137, 295-307.
62. Zohn, I.E., Anderson, K.V. and Niswander, L. (2007) The Hectd1 ubiquitin ligase is required for development of the head mesenchyme and neural tube closure. Dev. Biol., 306, 208-221.
63. Greene, N.D. and Copp, A.J. (2009) Development of the vertebrate central nervous system: formation of the neural tube. Prenat. Diagn., 29, 303-311.
64. Harris, M.J. (2001) Why are the genes that cause risk of human neural tube defects so hard to find? Teratology, 63, 165-166.
65. 2H), a mutation affecting development of the mouse neural tube, shows a deletion within the paired homeodomain of Pax-3. Cell, 67, 767-774.
66. Lakkis, M.M., Golden, J.A., O'Shea, K.S. and Epstein, J.A. (1999) Neurofibromin deficiency in mice causes exencephaly and is a modifier for Splotch neural tube defects. Dev. Biol., 212, 80-92.
67. Estibeiro, J.P., Brook, F.A. and Copp, A.J. (1993) Interaction between splotch (Sp) and curly tail (ct) mouse mutants in the embryonic development of neural tube defects. Development, 119, 113-121.
68. Martin, L.J., Machado, A.F., Loza, M.A., Mao, G.E., Lee, G.S., Hovland, D.N. Jr, Cantor, R.M. and Collins, M.D. (2003) Effect of arsenite, maternal age, and embryonic sex on spina bifida, exencephaly, and resorption rates in the splotch mouse. Birth Defects Res. (Part A), 67, 231-239.
69. Trembath, D., Sherbondy, A.L., Vandyke, D.C., Shaw, G.M., Todoroff, K., Lammer, E.J., Finnell, R.H., Marker, S., Lerner, G. and Murray, J.C. (1999) Analysis of select folate pathway genes, PAX3, and human T in a Midwestern neural tube defect population. Teratology, 59, 331-341.
70. Lu, W., Zhu, H., Wen, S., Laurent, C., Shaw, G.M., Lammer, E.J. and Finnell, R.H. (2007) Screening for novel PAX3 polymorphisms and risks of spina bifida. Birth Defects Res. A Clin. Mol. Teratol., 79, 45-49.
71. Van Straaten, H.W.M. and Copp, A.J. (2001) Curly tail: a 50-year history of the mouse spina bifida model. Anat. Embryol., 203, 225-237.
72. Neumann, P.E., Frankel, W.N., Letts, V.A., Coffin, J.M., Copp, A.J. and Bernfield, M. (1994) Multifactorial inheritance of neural tube defects: localization of the major gene and recognition of modifiers in ct mutant mice. Nat. Genet., 6, 357-362.
73. Ting, S.B., Wilanowski, T., Auden, A., Hall, M., Voss, A.K., Thomas, T., Parekh, V., Cunningham, J.M. and Jane, S.M. (2003) Inositol- and folate-resistant neural tube defects in mice lacking the epithelial-specific factor Grhl-3. Nat. Med., 9, 1513-1519.
74. Gustavsson, P., Greene, N.D., Lad, D., Pauws, E., de Castro, S.C., Stanier, P. and Copp, A.J. (2007) Increased expression of Grainyhead-like-3 rescues spina bifida in a folate-resistant mouse model. Hum. Mol. Genet., 16, 2640-2646.
75. Gustavsson, P., Copp, A.J. and Greene, N.D. (2008) Grainyhead genes and mammalian neural tube closure. Birth Defects Res. A Clin Mol. Teratol., 82, 728-735.
76. Greene, N.D.E. and Copp, A.J. (1997) Inositol prevents folate-resistant neural tube defects in the mouse. Nat. Med., 3, 60-66.
77. Cockroft, D.L., Brook, F.A. and Copp, A.J. (1992) Inositol deficiency increases the susceptibility to neural tube defects of genetically predisposed (curly tail) mouse embryos in vitro. Teratology, 45, 223-232.
78. Khandelwal, M., Reece, E.A., Wu, Y.K. and Borenstein, M. (1998) Dietary myo-inositol therapy in hyperglycemia-induced embryopathy. Teratology, 57, 79-84.
79. Wilson, M.P., Hugge, C., Bielinska, M., Nicholas, P., Majerus, P.W. and Wilson, D.B. (2009) Neural tube defects in mice with reduced levels of inositol 1,3,4-trisphosphate 5/6-kinase. Proc. Natl. Acad. Sci. U. S. A, 106, 9831-9835.
80. Krasnow, R.E., Wong, L.L. and Adler, P.N. (1995) Dishevelled is a component of the frizzled signaling pathway in Drosophila. Development, 121, 4095-4102.
81. Strutt, D.I., Weber, U. and Mlodzik, M. (1997) The role of RhoA in tissue polarity and Frizzled signalling. Nature, 387, 292-295.
82. McEwen, D.G. and Peifer, M. (2000) Wnt signaling: Moving in a new direction. Curr. Biol., 10, R562-R564.
83. Strutt, D. (2008) The planar polarity pathway. Curr. Biol., 18, R898-R902.
84. Wallingford, J.B., Rowning, B.A., Vogeli, K.M., Rothbächer, U., Fraser, S.E. and Harland, R.M. (2000) Dishevelled controls cell polarity during Xenopus gastrulation. Nature, 405, 81-85.
85. Park, M. and Moon, R.T. (2002) The planar cell-polarity gene stbm regulates cell behaviour and cell fate in vertebrate embryos. Nat. Cell Biol., 4, 20-25.
86. Jessen, J.R., Topczewski, J., Bingham, S., Sepich, D.S., Marlow, F., Chandrasekhar, A. and Solnica-Krezel, L. (2002) Zebrafish trilobite identifies new roles for Strabismus in gastrulation and neuronal movements. Nat. Cell Biol., 4, 610-615.
87. Montcouquiol, M., Rachel, R.A., Lanford, P.J., Copeland, N.G., Jenkins, N.A. and Kelley, M.W. (2003) Identification of Vangl2 and Scrb1 as planar polarity genes in mammals. Nature, 423, 173-177.
88. Henderson, D.J., Conway, S.J., Greene, N.D.E., Gerrelli, D., Murdoch, J.N., Anderson, R.H. and Copp, A.J. (2001) Cardiovascular defects associated with abnormalities in midline development in the loop-tail mouse mutant. Circ. Res., 89, 6-12.
89. Phillips, H.M., Rhee, H.J., Murdoch, J.N., Hildreth, V., Peat, J.D., Anderson, R.H., Copp, A.J., Chaudhry, B. and Henderson, D.J. (2007) Disruption of planar cell polarity signaling results in congenital heart defects and cardiomyopathy attributable to early cardiomyocyte disorganization. Circ. Res., 101, 137-145.
90. Vandenberg, A.L. and Sassoon, D.A. (2009) Non-canonical Wnt signaling regulates cell polarity in female reproductive tract development via van gogh-like 2. Development, 136, 1559-1570.
91. Kibar, Z., Vogan, K.J., Groulx, N., Justice, M.J., Underhill, D.A. and Gros, P. (2001) Ltap, a mammalian homolog of Drosophila Strabismus/ Van Gogh, is altered in the mouse neural tube mutant Loop-tail. Nat. Genet., 28, 251-255.
92. Murdoch, J.N., Doudney, K., Paternotte, C., Copp, A.J. and Stanier, P. (2001) Severe neural tube defects in the loop-tail mouse result from mutation of Lpp1, a novel gene involved in floor plate specification. Hum. Mol. Genet., 10, 2593-2601.
93. Murdoch, J.N., Henderson, D.J., Doudney, K., Gaston-Massuet, C., Phillips, H.M., Paternotte, C., Arkell, R., Stanier, P. and Copp, A.J. (2003) Disruption of scribble (Scrb1) causes severe neural tube defects in the circletail mouse. Hum. Mol. Genet., 12, 87-98.
94. Lu, X., Borchers, A.G., Jolicoeur, C., Rayburn, H., Baker, J.C. and Tessier-Lavigne, M. (2004) PTK7/CCK-4 is a novel regulator of planar cell polarity in vertebrates. Nature, 430, 93-98.
95. Doudney, K., Ybot-Gonzalez, P., Paternotte, C., Stevenson, R.E., Greene, N.D., Moore, G.E., Copp, A.J. and Stanier, P. (2005) Analysis of the planar cell polarity gene Vangl2 and its co-expressed paralogue Vangl1 in neural tube defect patients. Am. J. Med. Genet. A, 136A, 90-92.
96. Kibar, Z., Torban, E., McDearmid, J.R., Reynolds, A., Berghout, J., Mathieu, M., Kirillova, I., De Marco, P., Merello, E., Hayes, J.M. et al. (2007) Mutations in VANGL1 associated with neural-tube defects. N. Engl. J Med., 356, 1432-1437.
97. Kibar, Z., Bosoi, C.M., Kooistra, M., Salem, S., Finnell, R.H., De, M.P., Merello, E., Bassuk, A.G., Capra, V. and Gros, P. (2009) Novel mutations in VANGL1 in neural tube defects. Hum. Mutat., 30, E706- E715.
98. Torban, E., Patenaude, A.M., Leclerc, S., Rakowiecki, S., Gauthier, S., Andelfinger, G., Epstein, D.J. and Gros, P. (2008) Genetic interaction between members of the Vangl family causes neural tube defects in mice. Proc. Natl. Acad. Sci. U. S. A., 105, 3449-3454.
99. Carroll, E., Gerrelli, D., Gasca, S., Berg, E., Beier, D., Copp, A. and Klingensmith, J. (2003) Cordon-bleu is a conserved gene involved in neural tube formation. Dev. Biol., 262, 16-31.
100. Yamamoto, S., Nishimura, O., Misaki, K., Nishita, M., Minami, Y., Yonemura, S., Tarui, H. and Sasaki, H. (2008) Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex. Dev. Cell, 15, 23-36.
101. Etheridge, S.L., Ray, S., Li, S., Hamblet, N.S., Lijam, N., Tsang, M., Greer, J., Kardos, N., Wang, J., Sussman, D.J. et al. (2008) Murine dishevelled 3 functions in redundant pathways with dishevelled 1 and 2 in normal cardiac outflow tract, cochlea, and neural tube development. PLoS Genet., 4, e1000259.
102. Murdoch, J.N., Rachel, R.A., Shah, S., Beermann, F., Stanier, P., Mason, C.A. and Copp, A.J. (2001) Circletail, a new mouse mutant with severe neural tube defects: Chromosomal localisation and interaction with the loop-tail mutation. Genomics, 78, 55-63.
103. Shaw, G.M., Lu, W., Zhu, H., Yang, W., Briggs, F.B., Carmichael, S.L., Barcellos, L.F., Lammer, E.J. and Finnell, R.H. (2009) 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med. Genet., 10, 49.
104. Deak, K.L., Dickerson, M.E., Linney, E., Enterline, D.S., George, T.M., Melvin, E.C., Graham, F.L., Siegel, D.G., Hammock, P., Mehltretter, L. et al. (2005) Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2.. Birth Defects Res. A Clin. Mol. Teratol., 73, 868-875.
105. Zhu, H., Wicker, N.J., Shaw, G.M., Lammer, E.J., Hendricks, K., Suarez, L., Canfield, M. and Finnell, R.H. (2003) Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol. Genet. Metab., 78, 216-221.
106. Volcik, K.A., Shaw, G.M., Lammer, E.J., Zhu, H.P. and Finnell, R.H. (2003) Evaluation of infant methylenetetrahydrofolate reductase genotype, maternal vitamin use, and risk of high versus low level spina bifida defects. Birth Defects Res. (Part A), 67, 154-157.
107. Wilson, A., Platt, R., Wu, Q., Leclerc, D., Christensen, B., Yang, H., Gravel, R.A. and Rozen, R. (1999) A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol. Genet. Metab., 67, 317-323.
108. Toepoel, M., Steegers-Theunissen, R.P., Ouborg, N.J., Franke, B., Ladd, A.M., Joosten, P.H. and van Zoelen, E.J. (2009) Interaction of PDGFRA promoter haplotypes and maternal environmental exposures in the risk of spina bifida. Birth Defects Res. A Clin. Mol. Teratol., 85, 629-636.
109. Joosten, P.H., Toepoel, M., Mariman, E.C. and Van Zoelen, E.J. (2001) Promoter haplotype combinations of the platelet-derived growth factor alpha-receptor gene predispose to human neural tube defects. Nat. Genet., 27, 215-217.
110. Volcik, K.A., Shaw, G.M., Zhu, H.P., Lammer, E.J., Laurent, C. and Finnell, R.H. (2003) Associations between polymorphisms within the thymidylate synthase gene and spina bifida. Birth Defects Res. Part A Clin Mol. Teratol., 67, 924-928.
111. Henrichsen, C.N., Chaignat, E. and Reymond, A. (2009) Copy number variants, diseases and gene expression. Hum. Mol. Genet., 18, R1-R8.
112. Olshan, A.F., Shaw, G.M., Millikan, R.C., Laurent, C. and Finnell, R.H. (2005) Polymorphisms in DNA repair genes as risk factors for spina bifida and orofacial clefts. Am. J. Med. Genet., 135A, 268-273.
113. Zhu, H., Curry, S., Wen, S., Wicker, N.J., Shaw, G.M., Lammer, E.J., Yang, W., Jafarov, T. and Finnell, R.H. (2005) Are the betaine-homocysteine methyltransferase (BHMT and BHMT2) genes risk factors for spina bifida and orofacial clefts? Am. J. Med. Genet. A, 135, 274-277.
114. King, T.M., Au, K.S., Kirkpatrick, T.J., Davidson, C., Fletcher, J.M., Townsend, I., Tyerman, G.H., Shimmin, L.C. and Northrup, H. (2007) The impact of BRCA1 on spina bifida meningomyelocele lesions. Ann. Hum. Genet., 71, 719-728.
115. Davidson, C.M., Northrup, H., King, T.M., Fletcher, J.M., Townsend, I., Tyerman, G.H. and Au, K.S. (2008) Genes in glucose metabolism and association with spina bifida. Reprod. Sci., 15, 51-58.
116. Relton, C.L., Wilding, C.S., Pearce, M.S., Laffling, A.J., Jonas, P.A., Lynch, S.A., Tawn, E.J. and Burn, J. (2004) Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J. Med. Genet., 41, 256-260.
117. Zhu, H., Enaw, J.O., Ma, C., Shaw, G.M., Lammer, E.J. and Finnell, R.H. (2007) Association between CFL1 gene polymorphisms and spina bifida risk in a California population. BMC. Med. Genet., 8, 12.
118. Enaw, J.O., Zhu, H., Yang, W., Lu, W., Shaw, G.M., Lammer, E.J. and Finnell, R.H. (2006) CHKA and PCYT1A gene polymorphisms, choline intake and spina bifida risk in a California population. BMC Med., 4, 36.
119. Volcik, K.A., Zhu, H., Finnell, R.H., Shaw, G.M., Canfield, M. and Lammer, E.J. (2004) Evaluation of the Cited2 gene and risk for spina bifida and congenital heart defects. Am. J Med. Genet., 126A, 324-325.
120. Johnson, W.G., Stenroos, E.S., Spychala, J.R., Chatkupt, S., Ming, S.X. and Buyske, S. (2004) New 19 bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR): a risk factor for spina bifida acting in mothers during pregnancy? Am. J. Med. Genet., 124A, 339-345.
121. Parle-McDermott, A., Pangilinan, F., Mills, J.L., Kirke, P.N., Gibney, E.R., Troendle, J., O'Leary, V.B., Molloy, A.M., Conley, M., Scott, J.M. et al. (2007) The 19-bp deletion polymorphism in intron-1 of dihydrofolate reductase (DHFR) may decrease rather than increase risk for spina bifida in the Irish population. Am. J. Med. Genet. A, 143A, 1174-1180.
122. Van der Linden, I., Nguyen, U., Heil, S.G., Franke, B., Vloet, S., Gellekink, H., den, H.M. and Blom, H.J. (2007) Variation and expression of dihydrofolate reductase (DHFR) in relation to spina bifida. Mol. Genet. Metab., 91, 98-103.
123. Gos, M., Sliwerska, E. and Szpecht-Potocka, A. (2004) Mutation incidence in folate metabolism genes and regulatory genes in Polish families with neural tube defects. J. Appl. Genet., 45, 363-368.
124. O'Leary, V.B., Mills, J.L., Parle-McDermott, A., Pangilinan, F., Molloy, A.M., Cox, C., Weiler, A., Conley, M., Kirke, P.N., Scott, J.M. et al. (2005) Screening for new MTHFR polymorphisms and NTD risk. Am. J. Med. Genet. A, 138A, 99-106.
125. Vieira, A.R., Murray, J.C., Trembath, D., Orioli, I.M., Castilla, E.E., Cooper, M.E., Marazita, M.L., Lennon-Graham, F. and Speer, M. (2005) Studies of reduced folate carrier 1 (RFC1) A80G and 5,10-methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms with neural tube and orofacial cleft defects. Am. J. Med. Genet. A, 135, 220-223.
126. Grandone, E., Corrao, A.M., Colaizzo, D., Vecchione, G., Di, G.C., Paladini, D., Sardella, L., Pellegrino, M., Zelante, L., Martinelli, P. et al. (2006) Homocysteine metabolism in families from southern Italy with neural tube defects: role of genetic and nutritional determinants. Prenat. Diagn., 26, 1-5.
127. Munoz, J.B., Lacasana, M., Cavazos, R.G., Borja-Aburto, V.H., Galaviz-Hernandez, C. and Garduno, C.A. (2007) Methylenetetrahydrofolate reductase gene polymorphisms and the risk of anencephaly in Mexico. Mol. Hum. Reprod., 13, 419-424.
128. Dalal, A., Pradhan, M., Tiwari, D., Behari, S., Singh, U., Mallik, G.K., Das, V. and Agarwal, S. (2007) MTHFR 677C-.T and 1298A-.C polymorphisms: evaluation of maternal genotypic risk and association with level of neural tube defect. Gynecol. Obstet. Invest., 63, 146-150.
129. Gonzalez-Herrera, L., Castillo-Zapata, I., Garcia-Escalante, G. and Pinto-Escalante, D. (2007) A1298C polymorphism of the MTHFR gene and neural tube defects in the state of Yucatan, Mexico. Birth Defects Res. A Clin. Mol. Teratol., 79, 622-626.
130. Candito, M., Rivet, R., Herbeth, B., Boisson, C., Rudigoz, R.C., Luton, D., Journel, H., Oury, J.F., Roux, F., Saura, R. et al. (2008) Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter Case-control study. Am. J Med. Genet. A, 146A, 1128-1133.
131. Shang, Y., Zhao, H., Niu, B., Li, W.I., Zhou, R., Zhang, T. and Xie, J. (2008) Correlation of polymorphism of MTHFRs and RFC-1 genes with neural tube defects in China. Birth Defects Res. A Clin. Mol. Teratol., 82, 3-7.
132. O'Leary, V.B., Mills, J.L., Pangilinan, F., Kirke, P.N., Cox, C., Conley, M., Weiler, A., Peng, K., Shane, B., Scott, J.M. et al. (2005) Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol. Genet. Metab., 85, 220-227.
133. Van der Linden, I., Den Heijer, M., Afman, L.A., Gellekink, H., Vermeulen, S.H., Kluijtmans, L.A. and Blom, H.J. (2006) The methionine synthase reductase 66A.G polymorphism is a maternal risk factor for spina bifida. J. Mol. Med., 84, 1047-1054.
134. Parle-McDermott, A., McManus, E.J., Mills, J.L., O'Leary, V.B., Pangilinan, F., Cox, C., Weiler, A., Molloy, A.M., Conley, M., Watson, D. et al. (2003) Polymorphisms within the vitamin B12 dependent methylmalonyl-coA mutase are not risk factors for neural tube defects. Mol. Genet. Metab., 80, 463-468.
135. Jensen, L.E., Hoess, K., Whitehead, A.S. and Mitchell, L.E. (2005) The NAT1 C1095A polymorphism, maternal multivitamin use and smoking, and the risk of spina bifida. Birth Defects Res. A Clin. Mol. Teratol., 73, 512-516.
136. Jensen, L.E., Hoess, K., Mitchell, L.E. and Whitehead, A.S. (2006) Loss of function polymorphisms in NAT1 protect against spina bifida. Hum. Genet., 120, 52-57.
137. Lu, W., Zhu, H., Wen, S., Yang, W., Shaw, G.M., Lammer, E.J. and Finnell, R.H. (2008) Nicotinamide N-methyl transferase (NNMT) gene polymorphisms and risk for spina bifida. Birth Defects Res. A Clin. Mol. Teratol., 82, 670-675.
138. Deak, K.L., Boyles, A.L., Etchevers, H.C., Melvin, E.C., Siegel, D.G., Graham, F.L., Slifer, S.H., Enterline, D.S., George, T.M., Vekemans, M. et al. (2005) SNPs in the neural cell adhesion molecule 1 gene (NCAM1) may be associated with human neural tube defects. Hum. Genet., 117, 133-142.
139. Brown, K.S., Cook, M., Hoess, K., Whitehead, A.S. and Mitchell, L.E. (2004) Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. Birth Defects Res. Part A Clin. Mol. Teratol., 70, 101-106.
140. Van der Linden, I.J., Heil, S.G., den, H.M. and Blom, H.J. (2007) The 894G.T variant in the endothelial nitric oxide synthase gene and spina bifida risk. J. Hum. Genet., 52, 516-520.
141. Zhu, H., Yang, W., Lu, W., Zhang, J., Shaw, G.M., Lammer, E.J. and Finnell, R.H. (2006) A known functional polymorphism (Ile120Val) of the human PCMT1 gene and risk of spina bifida. Mol. Genet. Metab., 87, 66-70.
142. Zhu, H., Wicker, N.J., Volcik, K., Zhang, J., Shaw, G.M., Lammer, E.J., Suarez, L., Canfield, M. and Finnell, R.H. (2004) Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects. Mol. Genet. Metab., 81, 127-132.
143. Au, K.S., Northrup, H., Kirkpatrick, T.J., Volcik, K.A., Fletcher, J.M., Townsend, I.T., Blanton, S.H., Tyerman, G.H., Villarreal, G. and King, T.M. (2005) Promotor genotype of the platelet-derived growth factor receptor-alpha gene shows population stratification but not association with spina bifida meningomyelocele. Am. J. Med. Genet. A, 139, 194-198.
144. Zhang, J., Zhu, H., Yang, W., Shaw, G.M., Lammer, E.J. and Finnell, R.H. (2006) Phosphatidylethanolamine N-methyltransferase (PEMT) gene polymorphisms and risk of spina bifida. Am. J. Med. Genet. A, 140, 785-789.
145. Zhu, H.P., Lu, W., Laurent, C., Shaw, G.M., Lammer, E.J. and Finnell, R.H. (2005) Genes encoding catalytic subunits of protein kinase A and risk of spina bifida. Birth Defects Res. A Clin. Mol. Teratol., 73, 591-596.
146. Relton, C.L., Wilding, C.S., Laffling, A.J., Jonas, P.A., Burgess, T., Binks, K., Tawn, E.J. and Burn, J. (2004) Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol. Genet. Metab., 81, 273-281.
147. O'Leary, V.B., Pangilinan, F., Cox, C., Parle-McDermott, A., Conley, M., Molloy, A.M., Kirke, P.N., Mills, J.L., Brody, L.C. and Scott, J.M. (2006) Reduced folate carrier polymorphisms and neural tube defect risk. Mol. Genet. Metab., 87, 364-369.
148. Pei, L., Liu, J., Zhang, Y., Zhu, H. and Ren, A. (2008) Association of reduced folate carrier gene polymorphism and maternal folic acid use with neural tube defects. Am. J Med. Genet. B Neuropsychiatr. Genet.; Epub.
149. Jensen, L.E., Barbaux, S., Hoess, K., Fraterman, S., Whitehead, A.S. and Mitchell, L.E. (2004) The human T locus and spina bifida risk. Hum. Genet., 115, 475-482.
150. Swanson, D.A., Pangilinan, F., Mills, J.L., Kirke, P.N., Conley, M., Weiler, A., Frey, T., Parle-McDermott, A., O'Leary, V.B., Seltzer, R.R. et al. (2005) Evaluation of transcobalamin II polymorphisms as neural tube defect risk factors in an Irish population. Birth Defects Res. A Clin. Mol. Teratol., 73, 239-244.
151. Wen, S., Lu, W., Zhu, H., Yang, W., Shaw, G.M., Lammer, E.J., Islam, A. and Finnell, R.H. (2009) Genetic polymorphisms in the thioredoxin 2 (TXN2) gene and risk for spina bifida. Am. J. Med. Genet. A, 149A, 155-160.
152. Pangilinan, F., Geiler, K., Dolle, J., Troendle, J., Swanson, D.A., Molloy, A.M., Sutton, M., Conley, M., Kirke, P.N., Scott, J.M. et al. (2008) Construction of a high resolution linkage disequilibrium map to evaluate common genetic variation in TP53 and neural tube defect risk in an Irish population. Am. J Med. Genet. A, 146A, 2617-2625.
153. Wilding, C.S., Relton, C.L., Sutton, M.J., Jonas, P.A., Lynch, S.A., Tawn, E.J. and Burn, J. (2004) Thymidylate synthase repeat polymorphisms and risk of neural tube defects in a population from the northern United Kingdom. Birth Defects Res. Part A Clin. Mol. Teratol., 70, 483-485.
154. Mitchell, A., Pangilinan, F., Van der, M.J., Molloy, A.M., Troendle, J., Conley, M., Kirke, P.N., Scott, J.M., Brody, L.C. and Mills, J.L. (2009) Uncoupling protein 2 polymorphisms as risk factors for NTDs. Birth Defects Res. A Clin. Mol. Teratol., 85, 156-160.
155. Klootwijk, R., Groenen, P., Schijvenaars, M., Hol, F., Hamel, B., Straatman, H., Steegers-Theunissen, R., Mariman, E. and Franke, B. (2004) Genetic variants in ZIC1, ZIC2 and ZIC3 are not major risk factors for neural tube defects in humans. Am. J. Med. Genet., 124A, 40-47.
156. Copp, A.J., Checiu, I. and Henson, J.N. (1994) Developmental basis of severe neural tube defects in the loop-tail (Lp) mutant mouse: use of microsatellite DNA markers to identify embryonic genotype. Dev. Biol., 165, 20-29.
157. Kibar, Z., Underhill, D.A., Canonne-Hergaux, F., Gauthier, S., Justice, M.J. and Gros, P. (2001) Identification of a new chemically induced allele (Lp(m1Jus)) at the loop-tail locus: morphology, histology, and genetic mapping. Genomics, 72, 331-337.
158. Curtin, J.A., Quint, E., Tsipouri, V., Arkell, R.M., Cattanach, B., Copp, A.J., Fisher, E.M., Nolan, P.M., Steel, K.P., Brown, S.D.M. et al. (2003) Mutation of Celsr1 disrupts planar polarity of inner ear hair cells and causes severe neural tube defects in the mouse. Curr. Biol., 13, 1-20.
159. Wang, J., Hamblet, N.S., Mark, S., Dickinson, M.E., Brinkman, B.C., Segil, N., Fraser, S.E., Chen, P., Wallingford, J.B. and Wynshaw-Boris, A. (2006) Dishevelled genes mediate a conserved mammalian PCP pathway to regulate convergent extension during neurulation. Development, 133, 1767-1778.
160. Wang, Y., Guo, N. and Nathans, J. (2006) The role of Frizzled3 and Frizzled6 in neural tube closure and in the planar polarity of inner-ear sensory hair cells. J. Neurosci., 26, 2147-2156.
161. Qian, D., Jones, C., Rzadzinska, A., Mark, S., Zhang, X., Steel, K.P., Dai, X. and Chen, P. (2007) Wnt5a functions in planar cell polarity regulation in mice. Dev. Biol., 306, 121-133.
162. Satoh, W., Matsuyama, M., Takemura, H., Aizawa, S. and Shimono, A. (2008) Sfrp1, Sfrp2 and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse. Genesis, 46, spcone.
163. Stiefel, D., Shibata, T., Meuli, M., Duffy, P. and Copp, A.J. (2003) Tethering of the spinal cord in mouse fetuses and neonates with spina bifida. J. Neurosurg. (Spine), 99, 206-213.